Clinical trial
Paroxetine/Bupropion in Suicide Attempters/Ideators With Major Depression
NCT00429169 · New York State Psychiatric Institute, Other · Terminated
Key facts
| NCT number | NCT00429169 |
|---|---|
| Title | Paroxetine/Bupropion in Suicide Attempters/Ideators With Major Depression |
| Official title | Paroxetine Versus Bupropion for Suicide Ideators or Attempters With Major Depressive Disorder |
| Lead sponsor | New York State Psychiatric Institute, Other |
| Collaborators | National Institute of Mental Health (NIMH) NIH |
| Status | Terminated |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Depression |
| Intervention type | Drug |
| Interventions | Paroxetine, Bupropion |
| Enrollment | 101 |
| Start date | Jun 1, 2004 |
| Primary completion | Jan 1, 2010 |
| Completion | Jan 1, 2013 |
| First posted | Jan 31, 2007 |
| Last update posted | Oct 30, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: